Codexis, Inc. - Common Stock 정보 위키백과 회사 개요

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

History

Codexis is based in Redwood City, CA and was incorporated in 2002. It went public in April 2010 on NASDAQ, and in October, acquired Maxygen's MolecularBreeding technology portfolio.

Pharmaceutical

Codexis won the Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency (EPA) in 2006 for its work on a building block of Lipitor. It then won a second time in 2010 for its work with Merck & Co. on the active ingredient in Januvia.

Nutrition

In 2017, the company entered a partnership with Tate & Lyle to provide research and development for the production of new ingredients. That same year, Codexis announced a collaboration with Nestle to provide enzymes for metabolic disorders.

Biotherapeutics

In 2017, Codexis developed a recombinant phenylalanine ammonia-lyase (PAL) enzyme, to act as a substitute phenylalanine hydroxylase (PAH) enzyme for people who suffer from phenylketonuria. The enzyme was in-licensed by Nestle Health Sciences.

In 2020, Takeda Pharmaceutical announced a collaboration with Codexis to research and create gene therapies for rare diseases, including lysosomal storage disorders.

Life science

In June 2020, they announced a partnership with Molecular Assemblies to engineer enzymes for DNA synthesis.

Technology

Codexis uses directed evolution to develop its enzymes. Using this method, scientists genetically engineer genes, then screen the enzymes produced to see if it creates the properties needed for a specific reaction. Their protein engineering platform, called CodeEvolver, uses machine learning and high-throughput experimentation to learn protein sequence changes and their impacts on protein function.

출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗

Wikidata ↗

CDXS 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위

가격

$1.56

시가총액

$142M

P/E (TTM)

-3.1

EPS (TTM)

$-0.50

매출 (TTM)

$70M

배당 수익률

—

ROE

-82.8%

부채/자본

0.8

52주 범위

$1 – $3

CDXS 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의

10년 성과 매출, 순이익, 마진 및 EPS 추세

매출 및 순이익 $70M

2016-12-31 → 2025-12-31

EPS $-0.50

2019-12-31 → 2025-12-31

잉여현금흐름 $-24M

2016-12-31 → 2025-12-31

마진 -62.5%

가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?

지표

5년 추세

CDXS

동종업계 중앙값

P/E (TTM)

-3.1

17.5

P/S (TTM)

2.0

3.3

P/B

2.8

2.1

EV / EBITDA

-2.8

—

Price / FCF (주가 / FCF)

-5.9

—

수익성 총, 영업 및 순이익률; ROE, ROA, ROIC

지표

5년 추세

CDXS

동종업계 중앙값

Operating Margin (영업이익률)

-59.3%

—

Net Profit Margin (순이익률)

-62.5%

-56.5%

ROA

-29.6%

-17.2%

ROE

-82.8%

-41.3%

ROIC

-46.1%

—

재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성

지표

5년 추세

CDXS

동종업계 중앙값

Debt / Equity (부채 / 자기자본 비율)

0.8

369.6

Current Ratio (유동비율)

3.8

4.9

Quick Ratio (당좌 비율)

3.1

—

성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR

지표

5년 추세

CDXS

동종업계 중앙값

Revenue YoY (매출 YoY)

18.6%

—

Revenue CAGR 3Y (매출 CAGR 3년)

-20.2%

—

Revenue CAGR 5Y (매출 CAGR 5년)

0.38%

—

주당 지표 EPS, 주당 순자산, 주당 현금 흐름, 주당 배당금

지표

5년 추세

CDXS

동종업계 중앙값

EPS (Diluted) (EPS (희석))

$-0.50

—

자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율

지표

5년 추세

CDXS

동종업계 중앙값

CDXS 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력

매수 13 명의 애널리스트

적극 매수 4 30.8%
매수 6 46.2%
보유 3 23.1%
매도 0 0.0%
적극 매도 0 0.0%

12개월 목표 주가

6 명의 애널리스트 · 2026-08-13

중앙값 $7.00

← 모든 목표가 하회 $1.56

저가 $2.00

고가 $11.00

중앙값 목표 $7.00 +347.3%

평균 목표 $6.58 +320.7%

실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일

평균 서프라이즈

0.01%

기간	EPS Actual	EPS 예상	서프라이즈
2026년 6월 30일	$-0.13	$-0.14	0.01%
2026년 3월 31일	$-0.10	$-0.14	0.04%
2025년 12월 31일	$0.11	$-0.04	0.15%
2025년 9월 30일	$-0.22	$-0.15	-0.07%
2025년 6월 30일	$-0.16	$-0.19	0.03%
2025년 3월 31일	$-0.25	$-0.24	-0.01%
2024년 12월 31일	$-0.13	$-0.04	-0.09%

동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업

티커	시가총액	P/E	매출 YoY	순이익률	ROE	매출 총이익률
CDXS	$147M	-3.3	18.6%	-62.5%	-82.8%	—
DNA	$484M	-1.5	-25.1%	-183.8%	-55.8%	—
TKNO	$204M	-11.9	7.3%	-42.6%	-23.8%	33.2%
PACB	$565M	-1.0	3.9%	-341.5%	-1634.9%	28.6%
LAB	$495M	-6.4	-6.2%	-87.8%	-17.6%	49.9%
LFCR	$249M	-5.3	0.47%	-30.0%	-461.3%	31.3%
QSI	—	—	—	—	—	—
MXCT	$166M	-3.7	-14.5%	-135.1%	-24.6%	81.2%
QTRX	$297M	-2.5	1.1%	-77.1%	-36.4%	46.8%
SEER	—	-1.4	17.0%	—	—	—
NAUT	$247M	-4.1	—	—	-34.9%	—

전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름

손익계산서 16

CDXS의 연간 손익계산서 데이터
지표	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$70M	$59M	$70M	$139M	$105M	$69M	$68M	$61M	$50M	$49M	$42M	$35M
Cost of Revenue	$9M	$16M	$13M	$38M	$22M	$14M	$16M	$13M	$14M	$10M	$7M	$10M
R&D Expense	$52M	$46M	$59M	$80M	$56M	$44M	$34M	$30M	$30M	$22M	$21M	$23M
SG&A Expense	$47M	$55M	$53M	$52M	$49M	$35M	$32M	$29M	$29M	$25M	$22M	$22M
Operating Expenses	$112M	$118M	$138M	$173M	$127M	$93M	$81M	$72M	$73M	$57M	$50M	$54M
Operating Income	$-42M	$-59M	$-68M	$-35M	$-23M	$-24M	$-13M	$-11M	$-23M	$-9M	$-8M	$-19M
Interest Income	$3M	$4M	$4M	$1M	$459.0K	$405.0K	$1M	$671.0K	$147.0K	$60.0K	$19.0K	$18.0K
Other Non-op	$-5M	$-10M	$-12M	$124.0K	$1M	$-156.0K	$-656.0K	$-291.0K	$-92.0K	$-94.0K	·	·
Pretax Income	$-44M	$-65M	$-76M	$-33M	$-21M	$-24M	$-12M	$-11M	$-23M	$-9M	$-8M	$-19M
Income Tax	$47.0K	$34.0K	$69.0K	$276.0K	$189.0K	$339.0K	$17.0K	$-37.0K	$81.0K	$-40.0K	$-338.0K	$-256.0K
Net Income	$-44M	$-65M	$-76M	$-34M	$-21M	$-24M	$-12M	$-11M	$-23M	$-9M	$-8M	$-19M
EPS (Basic)	$-0.50	$-0.89	$-1.12	$-0.51	$-0.33	$-0.40	$-0.21	·	·	·	·	·
EPS (Diluted)	$-0.50	$-0.89	$-1.12	$-0.51	$-0.33	$-0.40	$-0.21	·	·	·	·	·
Shares (Basic)	87,142,000	73,408,000	68,131,000	65,344,000	64,568,000	59,360,000	56,525,000	·	·	·	·	·
Shares (Diluted)	87,142,000	73,408,000	68,131,000	65,344,000	64,568,000	59,360,000	56,525,000	·	·	·	·	·
EBITDA	$-36M	$-54M	$-68M	$-35M	$-23M	$-24M	$-13M	$-11M	$-23M	$-9M	$-8M	$-19M

대차대조표 29

CDXS의 연간 대차대조표 데이터
지표	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$51M	$19M	$65M	$114M	$117M	$149M	$90M	$53M	$31M	$19M	$23M	$26M
Short-term Investments	$27M	$54M	$0	·	·	·	·	·	·	·	·	·
Receivables	·	·	$10M	$32M	$25M	$14M	$9M	$12M	$11M	$6M	$7M	$4M
Inventory	$2M	$2M	$3M	$2M	$1M	$964.0K	$371.0K	$589.0K	$1M	$825.0K	$992.0K	$1M
Prepaid Expense	$6M	$4M	$5M	$5M	$6M	$3M	$3M	$1M	$984.0K	$1M	$1M	$1M
Other Current Assets	$500.0K	$500.0K	$600.0K	$700.0K	·	·	·	·	·	·	·	·
Current Assets	$97M	$99M	$93M	$163M	$162M	$184M	$114M	$68M	$45M	$27M	$33M	$33M
PP&E (Net)	$13M	$14M	$15M	$23M	$21M	$10M	$6M	$5M	$3M	$2M	$3M	$4M
PP&E (Gross)	$58M	$55M	$55M	$62M	$57M	$43M	$40M	$38M	$35M	$34M	$35M	$37M
Accum. Depreciation	$45M	$41M	$39M	$40M	$36M	$33M	$33M	$33M	$32M	$32M	$32M	$31M
Goodwill	$2M	$2M	$2M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M
Intangibles	·	·	·	·	·	·	·	·	·	$0	$3M	$6M
Other Non-current Assets	$883.0K	$1M	$1M	$350.0K	$276.0K	$294.0K	$178.0K	$1M	$302.0K	$259.0K	$310.0K	$294.0K
Total Assets	$148M	$149M	$137M	$250M	$246M	$222M	$149M	$79M	$54M	$36M	$45M	$48M
Accounts Payable	$2M	$3M	$6M	$3M	$3M	$3M	$3M	$3M	$4M	$4M	$3M	$5M
Accrued Liabilities	$3M	$6M	$5M	$15M	$13M	$10M	$7M	$5M	$4M	$2M	$2M	$3M
Current Liabilities	$25M	$24M	$36M	$49M	$33M	$25M	$15M	$18M	$25M	$12M	$15M	$14M
Capital Leases	$30M	$28M	$12M	$38M	$44M	$22M	$25M	$61.0K	$302.0K	·	·	·
Other Non-current Liabilities	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$2M	$2M	$2M	$3M
Total Liabilities	$97M	$82M	$50M	$106M	$82M	$52M	$44M	$23M	$29M	$17M	$22M	·
Long-term Debt	$40M	$29M	·	·	·	·	·	·	·	·	·	·
Total Debt	$40M	$29M	·	·	·	·	·	·	$302.0K	·	·	·
Common Stock	$9.0K	$8.0K	$7.0K	$6.0K	$6.0K	$6.0K	$6.0K	$5.0K	$5.0K	$4.0K	$4.0K	$4.0K
Paid-in Capital	$657M	$630M	$584M	$566M	$552M	$537M	$448M	$387M	$340M	$311M	$306M	$302M
Retained Earnings	$-607M	$-563M	$-498M	$-421M	$-388M	$-366M	$-342M	$-330M	$-315M	$-292M	$-284M	$-276M
AOCI	$8.0K	$52.0K	$0	·	·	·	·	$0	$-472.0K	$0	$405.0K	$-142.0K
Stockholders' Equity	$51M	$67M	$87M	$145M	$164M	$170M	$106M	$56M	$25M	$19M	$23M	$26M
Liabilities + Equity	$148M	$149M	$137M	$250M	$246M	$222M	$149M	$79M	$54M	$36M	$45M	$48M
Shares Outstanding	90,478,000	81,850,000	69,905,000	65,811,000	65,109,000	64,283,000	58,877,000	54,065,000	48,365,000	41,255,000	40,343,000	39,563,000

현금 흐름 17

CDXS의 연간 현금 흐름 데이터
지표	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$5M	$5M	$6M	$5M	·	·	·	·	·	·	·	·
Stock-based Comp	$10M	$13M	$10M	$15M	$12M	$8M	$7M	$8M	$7M	$6M	$5M	$5M
Deferred Tax	$-3.0K	$-2.0K	$0	$-7.0K	$-9.0K	$-8.0K	$-6.0K	$-29.0K	$12.0K	$-31.0K	$-330.0K	$110.0K
Amort. of Intangibles	·	·	·	·	·	·	·	$0	$0	$3M	$3M	$3M
Restructuring	$3M	$0	$3M	$3M	$0	$0	·	·	·	·	·	·
Other Non-cash	$10M	$-2M	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$-19M	$-49M	$-53M	$11M	$-14M	$-16M	$-13M	$-14M	$-9M	$-2M	$-433.0K	$321.0K
CapEx	$4M	$4M	$4M	$8M	$14M	$4M	$4M	$3M	$985.0K	$888.0K	$1M	$302.0K
Investing Cash Flow	$24M	$-57M	$-5M	$-14M	$-21M	$-6M	$-4M	$-3M	$-983.0K	$-846.0K	$-1M	$5M
Debt Issued	$10M	$30M	$0	$0	·	·	·	·	·	·	·	·
Net Debt Issued	$10M	$30M	·	·	·	·	·	·	·	·	·	·
Stock Issued	$17M	$31M	$9M	$0	$0	$86M	$0	$37M	$24M	$0	$0	$9.0K
Net Stock Activity	$17M	$31M	$9M	$0	$0	$86M	$50M	·	$24M	$0	$0	$9.0K
Financing Cash Flow	$28M	$61M	$8M	$-575.0K	$4M	$81M	$54M	$39M	$22M	$-490.0K	$-2M	$-611.0K
Net Change in Cash	$32M	$-46M	$-49M	$-3M	$-32M	$59M	$38M	$22M	$12M	$-3M	$-3M	$4M
Taxes Paid	·	$17.0K	$194.0K	$100.0K	$102.0K	$312.0K	$5.0K	$5.0K	$32.0K	$5.0K	$8.0K	$15.0K
Free Cash Flow	$-24M	$-54M	$-57M	$3M	$-28M	$-20M	$-16M	$-17M	$-10M	$-4M	$-2M	$19.0K

수익성 7

CDXS의 연간 수익성 데이터
지표	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Operating Margin	-59.3%	-98.6%	-97.0%	-25.2%	-21.7%	-34.6%	-18.3%	-18.6%	-45.9%	-17.5%	-18.6%	-54.1%
Net Margin	-62.5%	-110.0%	-108.7%	-24.2%	-20.3%	-34.8%	-17.4%	-17.9%	-46.0%	-17.5%	-18.1%	-54.0%
Pretax Margin	-62.4%	-109.9%	-108.6%	-24.0%	-20.1%	-34.3%	-17.4%	-18.0%	-45.8%	-17.6%	-18.9%	-54.7%
EBITDA Margin	-51.8%	-90.3%	-97.0%	-25.2%	-21.7%	-34.6%	-18.3%	-18.6%	-45.9%	-17.5%	-18.6%	-54.1%
ROA	-29.6%	-45.7%	-39.4%	-13.5%	-9.1%	-13.0%	-10.4%	-16.4%	-51.5%	-21.3%	-16.3%	-35.7%
ROE	-82.8%	-93.0%	-85.6%	-22.5%	-12.8%	-18.4%	-11.5%	-19.6%	-98.6%	-40.8%	-30.8%	-56.3%
ROIC	-46.1%	-61.1%	-78.7%	-24.3%	-13.9%	-14.3%	-11.9%	-20.0%	-92.8%	-44.6%	-32.5%	-71.7%

유동성 및 지급능력 4

CDXS의 연간 유동성 및 지급능력 데이터
지표	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	3.8	4.2	2.6	3.3	4.9	7.4	7.4	3.8	1.8	2.2	2.2	2.4
Quick Ratio	3.1	3.1	2.1	3.0	4.2	6.5	6.5	3.6	1.7	2.0	2.1	2.2
Debt / Equity	0.8	0.4	·	·	·	·	·	·	0.0	·	·	·
LT Debt / Equity	0.8	0.4	·	·	·	·	·	·	0.0	·	·	·

효율성 3

CDXS의 연간 효율성 데이터
지표	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.5	0.4	0.4	0.6	0.4	0.4	0.6	0.9	1.1	1.2	0.9	0.7
Inventory Turnover	5.2	7.3	5.4	23.9	20.9	20.6	32.6	15.5	15.4	10.7	5.5	6.7
Receivables Turnover	·	·	3.3	4.9	5.4	6.0	6.7	5.3	5.6	7.4	7.5	7.6

주당 5

CDXS의 연간 주당 데이터
지표	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$0.56	$0.82	$1.24	$2.20	$2.52	$2.65	$1.79	$1.03	$0.51	$0.46	$0.57	$0.67
Revenue / Share	$0.81	$0.81	$1.03	$2.12	$1.62	·	·	·	·	·	·	·
Cash Flow / Share	$-0.22	$-0.67	$-0.77	$0.17	$-0.22	·	·	·	·	·	·	·
Cash / Share	$0.56	$0.24	$0.93	$1.73	$1.79	$2.32	$1.54	$0.97	$0.65	$0.47	$0.58	$0.67
EPS (TTM)	$-0.50	$-0.89	$-1.12	$-0.51	$-0.33	$-0.40	$-0.21	·	·	·	·	·

성장률 3

CDXS의 연간 성장률 데이터
지표	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	18.6%	-15.4%	-49.4%	32.3%	51.7%	·	·	·	·	·	·	·
Revenue CAGR 3Y	-20.2%	-17.3%	0.52%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	0.38%	·	·	·	·	·	·	·	·	·	·	·

가치 평가 (TTM) 14

CDXS의 연간 가치 평가 (TTM) 데이터
지표	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$70M	$59M	$70M	$139M	$105M	$69M	$68M	$61M	$50M	$49M	$42M	$35M
Net Income TTM	$-44M	$-65M	$-76M	$-34M	$-21M	$-24M	$-12M	$-11M	$-23M	$-9M	$-8M	$-19M
Market Cap	$147M	$390M	$213M	$307M	$2.04B	$1.40B	$941M	$912M	$404M	$190M	$171M	$100M
Enterprise Value	$109M	$346M	·	·	·	·	·	·	$373M	·	·	·
P/E	-3.3	-5.4	-2.7	-9.1	-94.8	-54.6	-76.1	·	·	·	·	·
P/S	2.1	6.6	3.0	2.2	19.4	20.3	13.8	15.0	8.1	3.9	4.1	2.8
P/B	2.9	5.8	2.5	2.1	12.4	8.2	8.9	16.2	16.5	9.9	7.5	3.8
P / Tangible Book	3.1	6.1	2.5	2.2	12.6	8.4	·	·	·	·	·	·
P / Cash Flow	-7.6	-7.9	-4.1	27.2	-142.7	-85.2	-75.0	-64.7	-46.1	-70.3	-394.1	310.6
P / FCF	-6.2	-7.3	-3.7	103.0	-72.5	-69.4	-57.8	-54.1	-41.4	-52.9	-104.6	5247.3
EV / EBITDA	-3.0	-6.5	·	·	·	·	·	·	-16.2	·	·	·
EV / FCF	-4.6	-6.4	·	·	·	·	·	·	-38.3	·	·	·
EV / Revenue	1.6	5.8	·	·	·	·	·	·	7.5	·	·	·
Earnings Yield	-30.7%	-18.7%	-36.7%	-10.9%	-1.1%	-1.8%	-1.3%	·	·	·	·	·

손익계산서 16

CDXS의 분기별 손익계산서 데이터
지표	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$15M	$15M	$39M	$9M	$15M	$8M	$21M	$13M	$8M	$17M	$27M	$9M	$21M	$13M	$30M	$34M
Cost of Revenue	$4M	$2M	$2M	$2M	$2M	$3M	$4M	$4M	$3M	$5M	$3M	$2M	$3M	$5M	$8M	$10M
R&D Expense	$12M	$11M	$12M	$14M	$14M	$13M	$12M	$12M	$11M	$11M	$11M	$14M	$17M	$17M	$20M	$22M
SG&A Expense	$11M	$10M	$11M	$11M	$12M	$12M	$13M	$14M	$16M	$13M	$12M	$12M	$13M	$15M	$12M	$13M
Operating Expenses	$26M	$23M	$28M	$28M	$28M	$28M	$29M	$29M	$31M	$29M	$26M	$41M	$34M	$37M	$44M	$45M
Operating Income	$-11M	$-8M	$11M	$-19M	$-13M	$-20M	$-7M	$-17M	$-23M	$-12M	$282.0K	$-32M	$-13M	$-24M	$-13M	$-11M
Interest Income	$535.0K	$665.0K	$656.0K	$634.0K	$584.0K	$751.0K	$940.0K	$849.0K	$972.0K	$909.0K	$906.0K	$1M	$1M	$1M	$823.0K	$436.0K
Other Non-op	$-1M	$-1M	$-2M	$-1M	$-984.0K	$-942.0K	$-4M	$-5M	$-985.0K	$-516.0K	$-8M	$-4M	$-9.0K	$-25.0K	$-26.0K	$216.0K
Pretax Income	$-12M	$-9M	$10M	$-20M	$-13M	$-21M	$-10M	$-21M	$-23M	$-11M	$-7M	$-35M	$-12M	$-23M	$-12M	$-10M
Income Tax	$10.0K	$36.0K	$18.0K	$8.0K	$10.0K	$11.0K	$4.0K	$10.0K	$10.0K	$10.0K	$35.0K	$9.0K	$9.0K	$16.0K	$151.0K	$8.0K
Net Income	$-12M	$-9M	$10M	$-20M	$-13M	$-21M	$-10M	$-21M	$-23M	$-12M	$-7M	$-35M	$-12M	$-23M	$-13M	$-10M
EPS (Basic)	$-0.13	$-0.10	$0.13	$-0.22	$-0.16	$-0.25	$-0.12	$-0.29	$-0.32	$-0.16	$-0.11	$-0.50	$-0.17	$-0.34	$-0.19	$-0.15
EPS (Diluted)	$-0.13	$-0.10	$0.13	$-0.22	$-0.16	$-0.25	$-0.12	$-0.29	$-0.32	$-0.16	$-0.11	$-0.50	$-0.17	$-0.34	$-0.19	$-0.15
Shares (Basic)	91,053,000	90,768,000	-170,908,000	90,251,000	85,389,000	82,410,000	-138,854,000	72,032,000	70,376,000	69,854,000	-134,839,000	69,466,000	67,573,000	65,931,000	-130,466,000	65,426,000
Shares (Diluted)	91,053,000	90,768,000	-170,908,000	90,251,000	85,389,000	82,410,000	-138,854,000	72,032,000	70,376,000	69,854,000	-134,839,000	69,466,000	67,573,000	65,931,000	-130,466,000	65,426,000
EBITDA	$-11M	·	·	$-19M	$-13M	$-19M	·	$-17M	$-23M	$-12M	·	$-32M	$-13M	$-24M	·	$-11M

대차대조표 27

CDXS의 분기별 대차대조표 데이터
지표	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$27M	$37M	$51M	$25M	$27M	$18M	$19M	$37M	$19M	$58M	$65M	$75M	$92M	$103M	$114M	$109M
Short-term Investments	$28M	$29M	$27M	$33M	$40M	$41M	$54M	$53M	$55M	$27M	·	·	·	·	·	·
Inventory	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	·	$2M	$2M	$2M	·	$2M
Prepaid Expense	$3M	$4M	$6M	$5M	$3M	$4M	$4M	$3M	$3M	$5M	·	$5M	$4M	$5M	·	$5M
Other Current Assets	$500.0K	$400.0K	$500.0K	$500.0K	$100.0K	$500.0K	$500.0K	$300.0K	$900.0K	$500.0K	·	·	·	·	·	·
Current Assets	$72M	$80M	$97M	$76M	$89M	$78M	$99M	$113M	$91M	$108M	·	$103M	$120M	$130M	·	$146M
PP&E (Net)	$12M	$13M	$13M	$14M	$15M	$16M	$14M	$13M	$14M	$15M	·	$15M	$23M	$24M	·	$23M
PP&E (Gross)	$59M	$59M	$58M	$58M	$58M	$57M	$55M	$54M	$54M	$55M	·	$54M	$66M	$65M	·	$63M
Accum. Depreciation	$47M	$46M	$45M	$44M	$43M	$42M	$41M	$41M	$40M	$40M	·	$39M	$42M	$41M	·	$39M
Goodwill	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	·	$2M	$3M	$3M	$3M	$3M
Other Non-current Assets	$1M	$994.0K	$883.0K	$912.0K	$950.0K	$967.0K	$1M	$2M	$2M	$1M	·	$726.0K	$498.0K	$415.0K	·	$208.0K
Total Assets	$120M	$129M	$148M	$124M	$138M	$129M	$149M	$148M	$132M	$150M	·	$154M	$207M	$218M	·	$235M
Accounts Payable	$3M	$2M	$2M	$2M	$1M	$6M	$3M	$4M	$4M	$3M	·	$3M	$4M	$4M	·	$3M
Accrued Liabilities	$3M	$3M	$3M	$3M	$3M	$5M	$6M	$7M	$5M	$5M	·	$9M	$7M	$8M	·	$13M
Current Liabilities	$24M	$15M	$25M	$18M	$15M	$21M	$24M	$35M	$31M	$29M	·	$38M	$36M	$38M	·	$32M
Capital Leases	$28M	$29M	$30M	$26M	$27M	$27M	$28M	$9M	$10M	$11M	·	$13M	$35M	$37M	·	$40M
Other Non-current Liabilities	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	·	$1M	$1M	$1M	·	$1M
Total Liabilities	$87M	$86M	$97M	$85M	$83M	$79M	$82M	$75M	$71M	$70M	·	$63M	$83M	$92M	·	$81M
Long-term Debt	$41M	$40M	$40M	$40M	$39M	$29M	·	$29M	$28M	$28M	·	·	·	·	·	·
Total Debt	$41M	·	·	$40M	$39M	$29M	·	$29M	$28M	$28M	·	·	·	·	·	·
Common Stock	$9.0K	$9.0K	$9.0K	$9.0K	$9.0K	$8.0K	$8.0K	$8.0K	$7.0K	$7.0K	·	$6.0K	$6.0K	$6.0K	·	$6.0K
Paid-in Capital	$660M	$659M	$657M	$655M	$652M	$633M	$630M	$626M	$593M	$588M	·	$582M	$580M	$570M	·	$563M
Retained Earnings	$-627M	$-615M	$-607M	$-616M	$-597M	$-583M	$-563M	$-552M	$-532M	$-509M	·	$-490M	$-455M	$-444M	·	$-409M
AOCI	$-13.0K	$-11.0K	$8.0K	$12.0K	$-3.0K	$14.0K	$52.0K	$126.0K	$-23.0K	$-16.0K	·	·	·	·	·	·
Stockholders' Equity	$33M	$43M	$51M	$39M	$56M	$50M	$67M	$73M	$61M	$79M	$87M	$92M	$124M	$126M	$145M	$154M
Liabilities + Equity	$120M	$129M	$148M	$124M	$138M	$129M	$149M	$148M	$132M	$150M	·	$154M	$207M	$218M	·	$235M
Shares Outstanding	91,388,000	90,894,000	90,478,000	90,281,000	90,254,000	82,841,000	81,850,000	81,376,000	70,914,000	70,554,000	·	69,827,000	69,804,000	66,696,000	·	65,613,000

현금 흐름 15

CDXS의 분기별 현금 흐름 데이터
지표	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	·	·	·	·
Stock-based Comp	$2M	$1M	$2M	$3M	$3M	$2M	$3M	$3M	$5M	$3M	$2M	$2M	$3M	$3M	$3M	$5M
Restructuring	·	·	·	·	·	·	$0	$0	$0	$0	$0	$3M	$72.0K	$72.0K	$3M	$0
Other Non-cash	·	·	·	·	·	$3M	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$-10M	$-13M	$20M	$-8M	$-18M	$-14M	$-16M	$-13M	$-12M	$-8M	$-11M	$-16M	$-16M	$-9M	$5M	$20M
CapEx	$898.0K	$176.0K	$520.0K	$182.0K	$3M	$1M	$2M	$1M	$395.0K	$1M	$-380.0K	$678.0K	$2M	$3M	$-33.0K	$1M
Investing Cash Flow	$175.0K	$-1M	$6M	$6M	$-367.0K	$12M	$-3M	$2M	$-27M	$-29M	$1M	$-1M	$-2M	$-3M	$33.0K	$-1M
Debt Issued	·	·	$0	$0	$10M	$0	$0	$0	$0	$30M	$0	$0	$0	$0	·	·
Net Debt Issued	·	·	·	·	·	$0	·	·	·	$30M	·	·	·	·	·	·
Stock Issued	·	·	$-1.0K	$0	·	·	$-1.0K	$31M	$0	$0	$0	$0	$7M	$2M	$0	$0
Net Stock Activity	·	·	·	·	·	·	·	·	·	$0	·	·	·	$2M	·	·
Financing Cash Flow	$66.0K	$-14.0K	$180.0K	$-111.0K	$27M	$1M	$1M	$30M	$-197.0K	$29M	$0	$-108.0K	$7M	$1M	$339.0K	$133.0K
Net Change in Cash	$-9M	$-14M	$26M	$-1M	$8M	$-944.0K	$-18M	$19M	$-39M	$-7M	$-10M	$-18M	$-11M	$-11M	$5M	$19M
Taxes Paid	·	·	·	·	·	$0	·	·	·	$17.0K	·	·	·	·	·	·
Free Cash Flow	·	·	·	·	·	$-15M	·	·	·	$-9M	·	·	·	$-12M	·	·

수익성 7

CDXS의 분기별 수익성 데이터
지표	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-75.3%	·	·	-220.3%	-83.9%	-271.6%	·	-129.0%	-284.9%	-69.6%	·	-345.6%	-59.2%	-182.3%	·	-30.9%
Net Margin	-80.5%	·	·	-228.1%	-86.6%	-274.3%	·	-160.8%	-285.2%	-67.4%	·	-376.3%	-54.0%	-174.2%	·	-29.0%
Pretax Margin	-80.4%	·	·	-228.0%	-86.5%	-274.1%	·	-160.8%	-285.1%	-67.3%	·	-376.2%	-54.0%	-174.1%	·	-29.0%
EBITDA Margin	-75.3%	·	·	-220.3%	-83.9%	-255.8%	·	-129.0%	-284.9%	-69.6%	·	-345.6%	-59.2%	-182.3%	·	-30.9%
ROA	-9.3%	·	·	-14.4%	-9.8%	-14.9%	·	-13.6%	-13.4%	-6.3%	·	-17.9%	-5.2%	-10.0%	·	-4.3%
ROE	-27.1%	·	·	-35.0%	-22.7%	-32.1%	·	-25.0%	-24.5%	-11.2%	·	-28.4%	-8.1%	-15.9%	·	-6.2%
ROIC	-15.2%	·	·	-24.2%	-13.6%	-26.0%	·	-16.2%	-25.3%	-11.1%	·	-35.0%	-10.2%	-18.8%	·	-6.9%

유동성 및 지급능력 4

CDXS의 분기별 유동성 및 지급능력 데이터
지표	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	3.1	·	·	4.1	5.8	3.7	·	3.2	3.0	3.7	·	2.7	3.4	3.4	·	4.6
Quick Ratio	2.3	·	·	3.2	4.4	2.9	·	2.6	2.4	2.9	·	1.9	2.6	2.7	·	3.4
Debt / Equity	1.2	·	·	1.0	0.7	0.6	·	0.4	0.5	0.4	·	·	·	·	·	·
LT Debt / Equity	1.0	·	·	1.0	0.7	0.6	·	0.4	0.5	0.4	·	·	·	·	·	·

효율성 2

CDXS의 분기별 효율성 데이터
지표	추세	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.1	·	·	0.1	0.1	0.1	·	0.1	0.0	0.1	·	0.0	0.1	0.1	·	0.1
Inventory Turnover		2.0	·	·	1.2	1.0	1.3	·	2.0	1.6	2.2	·	1.1	1.7	2.5	·	7.2

주당 5

CDXS의 분기별 주당 데이터
지표	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.36	·	·	$0.43	$0.62	$0.60	·	$0.90	$0.87	$1.12	·	$1.31	$1.78	$1.89	·	$2.35
Revenue / Share	$0.16	·	·	$0.10	$0.18	$0.09	·	$0.18	$0.11	$0.24	·	$0.13	$0.32	$0.20	·	$0.53
Cash Flow / Share	·	·	·	·	·	$-0.17	·	·	·	$-0.11	·	·	·	$-0.14	·	·
Cash / Share	$0.30	·	·	$0.28	$0.30	$0.22	·	$0.46	$0.26	$0.82	·	$1.07	$1.32	$1.54	·	$1.66
EPS (TTM)	$-0.61	$-0.73	·	$-0.92	$-1.02	$-1.02	·	$-1.27	$-1.15	$-1.17	·	$-1.16	$-0.70	$-0.66	·	$-0.29

가치 평가 (TTM) 14

CDXS의 분기별 가치 평가 (TTM) 데이터
지표	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$54M	$47M	·	$44M	$44M	$45M	·	$47M	$56M	$61M	·	$78M	$107M	$121M	·	$145M
Net Income TTM	$-54M	$-62M	·	$-74M	$-77M	$-76M	·	$-90M	$-81M	$-81M	·	$-79M	$-47M	$-44M	·	$-19M
Market Cap	$207M	·	·	$220M	$220M	$223M	·	$251M	$220M	$246M	·	$132M	$195M	$276M	·	$398M
Enterprise Value	$192M	·	·	$201M	$193M	$192M	·	$189M	$175M	$189M	·	·	·	·	·	·
P/E	-3.7	-2.2	·	-2.7	-2.4	-2.6	·	-2.4	-2.7	-3.0	·	-1.6	-4.0	-6.3	·	-20.9
P/S	3.8	·	·	5.0	5.0	4.9	·	5.3	4.0	4.1	·	1.7	1.8	2.3	·	2.7
P/B	6.3	·	·	5.7	4.0	4.5	·	3.4	3.6	3.1	·	1.4	1.6	2.2	·	2.6
P / Tangible Book	6.8	3.6	·	6.1	4.1	4.7	·	3.5	3.7	3.2	·	1.5	1.6	2.2	·	2.6
P / Cash Flow	·	·	·	·	·	-16.2	·	·	·	-31.6	·	·	·	-30.0	·	·
P / FCF	·	·	·	·	·	-14.8	·	·	·	-27.6	·	·	·	-23.5	·	·
EV / EBITDA	-17.1	·	·	-10.6	-15.0	-10.0	·	-11.4	-7.7	-15.9	·	·	·	·	·	·
EV / FCF	·	·	·	·	·	-12.8	·	·	·	-21.2	·	·	·	·	·	·
EV / Revenue	3.6	·	·	4.5	4.4	4.2	·	4.0	3.1	3.1	·	·	·	·	·	·
Earnings Yield	-27.0%	-44.8%	·	-37.7%	-41.8%	-37.9%	·	-41.2%	-37.1%	-33.5%	·	-61.4%	-25.0%	-15.9%	·	-4.8%

재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년

손익계산서

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
매출	$70M	$59M	$70M	$139M	$105M
영업이익률 %	-59.3%	-98.6%	-97.0%	-25.2%	-21.7%
순이익	$-44M	$-65M	$-76M	$-34M	$-21M
희석 EPS	$-0.50	$-0.89	$-1.12	$-0.51	$-0.33

대차대조표

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
부채 / 자기자본 비율	0.8	0.4	—	—	—
유동비율	3.8	4.2	2.6	3.3	4.9
당좌 비율	3.1	3.1	2.1	3.0	4.2

현금 흐름

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
잉여현금흐름	$-24M	$-54M	$-57M	$3M	$-28M

나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목

📊

중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.

선택 항목이 저장되어 모든 티커에서 유지됩니다.

기관 투자자 (13F) 156개의 제출자 · $120.9M 전체 · 기준일 2026년 6월 30일

분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.

기관 활동 — Q2 2026 대 이전 분기

신규 포지션	청산 포지션	증가함	감소	순주식 변동
32 (+4 이전 분기 대비)	11 (-10 이전 분기 대비)	50 (+4 이전 분기 대비)	41 (+8 이전 분기 대비)	+6.7M

Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.

기관	가치	주식	% 추적된 13F 중	유형
Opaleye Management Inc.	$15,334,100	6,785,000	12.69%	주식
Aberdeen Group plc	$15,300,096	6,769,954	12.66%	주식
MILLENNIUM MANAGEMENT LLC	$12,541,054	5,549,139	10.38%	주식
Telemark Asset Management, LLC	$8,692,889	3,846,411	7.19%	주식
AMERIPRISE FINANCIAL INC	$8,609,334	3,809,440	7.12%	주식
Nantahala Capital Management, LLC	$8,189,365	3,623,613	6.78%	주식
VANGUARD CAPITAL MANAGEMENT LLC	$8,174,666	3,617,109	6.76%	주식
GEODE CAPITAL MANAGEMENT, LLC	$4,204,899	1,860,140	3.48%	주식
STATE STREET CORP	$3,970,400	1,756,814	3.29%	주식
JACOBS LEVY EQUITY MANAGEMENT, INC	$3,006,263	1,330,205	2.49%	주식
VANGUARD PORTFOLIO MANAGEMENT LLC	$2,954,206	1,307,171	2.44%	주식
Assenagon Asset Management S.A.	$2,888,746	1,278,206	2.39%	주식
D. E. Shaw & Co., Inc.	$2,500,229	1,106,296	2.07%	주식
Tallon Kerry Patrick	$2,018,337	403,667	1.67%	주식
TWO SIGMA INVESTMENTS, LP	$1,574,314	696,599	1.30%	주식
FRANKLIN RESOURCES INC	$1,533,726	678,640	1.27%	주식
VANGUARD FIDUCIARY TRUST CO	$1,313,191	581,058	1.09%	주식
Man Group plc	$1,278,240	565,593	1.06%	주식
Post Resch Tallon Group Inc.	$1,273,460	563,478	1.05%	주식
PERKINS CAPITAL MANAGEMENT INC	$1,188,986	526,100	0.98%	주식
ALGERT GLOBAL LLC	$973,857	430,910	0.81%	주식
TUDOR INVESTMENT CORP ET AL	$808,910	357,925	0.67%	주식
BlackRock, Inc.	$648,681	287,027	0.54%	주식
PLATINUM INVESTMENT MANAGEMENT LTD	$597,689	264,464	0.49%	주식
Potomac Capital Management, Inc.	$587,600	260,000	0.49%	주식
DIMENSIONAL FUND ADVISORS LP	$583,674	258,263	0.48%	주식
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$547,397	242,211	0.45%	주식
XTX Topco Ltd	$543,817	240,627	0.45%	주식
UBS Group AG	$542,188	239,906	0.45%	주식
FMR LLC	$457,501	202,434	0.38%	주식
GOLDMAN SACHS GROUP INC	$389,726	172,445	0.32%	주식
Cubist Systematic Strategies, LLC	$359,610	147,381	0.30%	주식
BARCLAYS PLC	$347,740	153,867	0.29%	주식
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$334,595	148,051	0.28%	주식
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$284,552	125,908	0.24%	주식
STRS OHIO	$273,460	121,000	0.23%	주식
JANE STREET GROUP, LLC	$261,857	115,866	0.22%	주식
MARSHALL WACE, LLP	$254,791	112,739	0.21%	주식
Stonepine Capital Management, LLC	$247,836	109,662	0.21%	주식
RHUMBLINE ADVISERS	$233,449	103,301	0.19%	주식
CITADEL ADVISORS LLC	$227,295	100,573	0.19%	주식
ALLIANCEBERNSTEIN L.P.	$206,081	126,430	0.17%	주식
WELLS FARGO & COMPANY/MN	$176,113	77,926	0.15%	주식
Bank of New York Mellon Corp	$174,178	77,070	0.14%	주식
LPL Financial LLC	$173,026	76,560	0.14%	주식
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$161,879	71,628	0.13%	주식
BANK OF AMERICA CORP /DE/	$145,582	64,417	0.12%	주식
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	$144,082	63,753	0.12%	주식
Numerai GP LLC	$136,072	60,209	0.11%	주식
PANAGORA ASSET MANAGEMENT INC	$131,532	58,200	0.11%	주식
Mariner, LLC	$123,484	54,637	0.10%	주식
MetLife Investment Management, LLC	$117,545	52,011	0.10%	주식
ENVESTNET ASSET MANAGEMENT INC	$116,108	51,375	0.10%	주식
LOS ANGELES CAPITAL MANAGEMENT LLC	$108,763	48,125	0.09%	주식
IEQ CAPITAL, LLC	$104,559	46,265	0.09%	주식
TWO SIGMA ADVISERS, LP	$96,822	59,400	0.08%	주식
RENAISSANCE TECHNOLOGIES LLC	$93,790	41,500	0.08%	주식
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	$89,957	39,804	0.07%	주식
CITIGROUP INC	$86,660	38,345	0.07%	주식
Frec Markets, Inc.	$84,228	37,269	0.07%	주식
OSAIC HOLDINGS, INC.	$82,186	36,366	0.07%	주식
COMMONWEALTH EQUITY SERVICES, LLC	$81,820	36,204	0.07%	주식
BANK OF MONTREAL /CAN/	$79,095	34,998	0.07%	주식
Krilogy Financial LLC	$78,705	34,825	0.07%	주식
MORGAN STANLEY	$77,462	34,275	0.06%	주식
Invesco Ltd.	$77,181	34,151	0.06%	주식
Dynamic Technology Lab Private Ltd	$74,000	33,000	0.06%	주식
Vanguard Global Advisers, LLC	$73,681	32,602	0.06%	주식
MERCER GLOBAL ADVISORS INC /ADV	$73,111	32,350	0.06%	주식
AMERICAN CENTURY COMPANIES INC	$68,932	30,501	0.06%	주식
BLAIR WILLIAM & CO/IL	$68,295	30,219	0.06%	주식
EVERGREEN CAPITAL MANAGEMENT LLC	$65,540	29,000	0.05%	주식
CWM, LLC	$63,696	39,077	0.05%	주식
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC	$61,418	25,275	0.05%	주식
Nuveen Asset Management, LLC	$59,902	12,558	0.05%	주식
PRUDENTIAL FINANCIAL INC	$59,619	26,380	0.05%	주식
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$56,963	25,205	0.05%	주식
Cerity Partners LLC	$53,695	23,759	0.04%	주식
VANGUARD GROUP INC	$53,141	32,602	0.04%	주식
INTECH INVESTMENT MANAGEMENT LLC	$48,486	21,454	0.04%	주식
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$45,426	20,100	0.04%	콜 옵션
Police & Firemen's Retirement System of New Jersey	$43,937	19,441	0.04%	주식
VOYA INVESTMENT MANAGEMENT LLC	$41,948	18,561	0.03%	주식
Vanguard Personalized Indexing Management, LLC	$40,562	17,948	0.03%	주식
Simplicity Wealth,LLC	$39,410	17,438	0.03%	주식
NEW YORK STATE COMMON RETIREMENT FUND	$38,167	16,888	0.03%	주식
CITADEL ADVISORS LLC	$35,708	15,800	0.03%	콜 옵션
Creative Planning	$35,003	15,488	0.03%	주식
BNP PARIBAS FINANCIAL MARKETS	$34,942	15,461	0.03%	주식
Navalign, LLC	$34,668	15,340	0.03%	주식
EP Wealth Advisors, LLC	$34,526	15,277	0.03%	주식
China Universal Asset Management Co., Ltd.	$32,693	14,466	0.03%	주식
ProShare Advisors LLC	$32,324	14,303	0.03%	주식
Elmwood Wealth Management, Inc.	$28,691	12,695	0.02%	주식
NORTHERN TRUST CORP	$27,992	12,386	0.02%	주식
OXFORD ASSET MANAGEMENT LLP	$27,335	12,095	0.02%	주식
Graham Capital Management, L.P.	$27,287	12,074	0.02%	주식
Tower Research Capital LLC (TRC)	$27,244	12,055	0.02%	주식
Abel Hall, LLC	$26,930	11,916	0.02%	주식
Caerus Investment Advisors, LLC	$26,297	11,636	0.02%	주식

회사 내부자 40 명의 내부자 · 19 임원 · 20 이사

내부자	역할	마지막 활동	보유 주식 수	매도 12개월	순매수/매도 12개월
John J Nicols	President and CEO	2018년 6월 11일 M	1,072,679	0	$0
Peter M Strumph	Interim President and CEO	2012년 6월 1일 A	60,756	0	$0
Alan Shaw	President and CEO	2011년 12월 16일 S	202,000	0	$0
Georgia Erbez	Chief Financial Officer	2025년 2월 5일 A	76,875	0	$0
Sriram Ryali	Chief Financial Officer	2024년 1월 1일 A	175,791	0	$0
Gordon Sangster	SVP & Chief Financial Officer	2018년 5월 24일 S	153,189	0	$0
David D O'Toole	SVP & Chief Financial Officer	2013년 9월 4일 F	110,687	0	$0
Brian Paul Dowd	Interim CFO	2012년 6월 1일 A	28,310	0	$0
Robert J Lawson	SVP and CFO	2011년 5월 11일 P	44,000	0	$0
Kevin Norrett	Chief Operating Officer	2025년 2월 5일 A	177,327	0	$0
Alison Moore	Chief Technical Officer	2025년 2월 5일 A	175,571	0	$0
Margaret Nell Fitzgerald	Chief Legal and Compliance Officer	2024년 1월 1일 A	133,770	0	$0
James Lalonde	SVP, R&D	2018년 7월 17일 S	195,066	0	$0
Michael D. Aldridge	Senior Vice President, Corporate & Strategic Development	2018년 5월 17일 M	0	0	$0
Douglas T. Sheehy	EVP, Chief Administrative Officer, General Counsel & Secretary	2016년 3월 5일 F	247,617	0	$0
Matthew Tobin	SVP, Research & Development	2013년 5월 16일 M	78,707	0	$0
David L. Anton	SVP, BioIndustrials	2013년 2월 10일 F	93,777	0	$0
Seufer-Wasserthal Peter	SVP, Pharmaceuticals	2013년 1월 24일 A	93,064	0	$0
Joseph J. Sarret	SVP and CBO	2012년 3월 7일 A	74,000	0	$0
Raymond De Vre	이사	2026년 6월 17일 A	84,811	1	$-6,174
Esther Martinborough	이사	2026년 6월 17일 A	129,036	0	$0
Christos Richards	이사	2026년 6월 17일 A	85,133	0	$0
Cynthia Collins	이사	2026년 6월 17일 A	112,157	0	$0
Stephen George Dilly	이사	2026년 6월 17일 A	673,053	0	$0
Rahul Singhvi	이사	2026년 6월 17일 A	137,052	0	$0
David V Smith	이사	2026년 6월 17일 A	105,705	0	$0
PARKER H STEWART	이사	2026년 6월 17일 A	143,583	0	$0
Dennis P Wolf	이사	2025년 6월 10일 A	147,903	0	$0
Byron L Dorgan	이사	2024년 6월 11일 A	223,581	0	$0
Patrick Y Yang	이사	2018년 7월 19일 S	304,157	0	$0
Kathleen Sereda Glaub	이사	2018년 7월 18일 S	98,120	0	$0
Thomas R Baruch	이사	2018년 6월 26일 S	153,093	0	$0
Bernard J Kelley	이사	2018년 6월 21일 S	225,668	0	$0
Pam P. Cheng	이사	2018년 6월 11일 A	64,642	0	$0
Alexander Karsner	이사	2014년 1월 2일 A	78,519	0	$0
Bruce A Pasternack	이사	2010년 8월 24일 P	10,000	0	$0
James R Sulat	이사	2010년 4월 27일 J	5,957,108	0	$0
Brazil Holding B.V. Shell	10% 소유주	2011년 5월 31일 J	5,573,319	0	$0
Equilon Enterprises LLC	10% 소유주	2011년 5월 20일 J	5,573,319	0	$0
MAXYGEN INC	10% 소유주	2010년 12월 14일 J	524,643	0	$0

SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당

행동주의자 및 5% 이상 소유자 3 보유

SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.

제출자	제출됨	지분	상태	목적	제출
John Nicols	2021년 2월 16일	—	최초 제출	—	SEC
– I.RS. IDENTIFICATION NO. OF ABOVE PERSON RAÍZEN ENERGIA S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON SHELL BRAZIL HOLDING B.V., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ROYAL DUTCH SHELL PLC, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN S.A. INDUSTRIA E COMÉRCIO, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN INVESTIMENTOS E PARTICIPAÇÕES S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN LIMITED ×2 제출 서류	2015년 5월 26일	—	최초 제출	—	SEC
– I.RS. IDENTIFICATION NO. OF ABOVE PERSON RAIZEN ENERGIA PARTICIPA Ç Õ ES S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ISPAGNAC PARTICIPA Ç Õ ES LTDA., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ROYAL DUTCH SHELL PLC, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN S.A. INDUSTRIA E COM É RCIO, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN LIMITED	2011년 6월 7일	—	최초 제출	—	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF 보유 현황 26 ETF 보유

가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.

펀드	비중	단위	기준일	출처
QQQS · Invesco Exchange-Traded Fund Trust …	0.26%	40,370 SH	2026년 8월 8일	일간
IWC · iShares Trust	0.03%	290,804 SH	2026년 8월 8일	일간
BIB · ProShares Trust	0.01%	3,341 NS	2026년 5월 31일	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0.01%	496,936 SH	2026년 8월 8일	일간
VTWG · VANGUARD SCOTTSDALE FUNDS	0.01%	78,444 SH	2026년 8월 8일	일간
IBB · iShares Trust	0.01%	613,531 SH	2026년 8월 8일	일간
IBBQ · Invesco Exchange-Traded Fund Trust …	0.01%	4,900 SH	2026년 8월 8일	일간
RSSL · Global X Funds	0.01%	38,712 NS	2026년 4월 30일	N-PORT
IWO · iShares Trust	0.01%	679,206 SH	2026년 8월 8일	일간
ITWO · ProShares Trust	0.01%	4,198 NS	2026년 5월 31일	N-PORT
IWM · iShares Trust	0.00%	2,240,076 SH	2026년 8월 8일	일간
UWM · ProShares Trust	0.00%	3,283 NS	2026년 5월 31일	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0.00%	71,405 SH	2026년 8월 8일	일간
AVSC · AMERICAN CENTURY ETF TRUST	0.00%	28,868 NS	2026년 5월 31일	N-PORT
URTY · ProShares Trust	0.00%	3,320 NS	2026년 5월 31일	N-PORT
IWN · iShares Trust	0.00%	128,823 SH	2026년 8월 8일	일간
HDG · ProShares Trust	0.00%	83 NS	2026년 5월 31일	N-PORT
DFAS · Dimensional ETF Trust	0.00%	52,788 NS	2026년 4월 30일	N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS	0.00%	2,554 NS	2026년 5월 31일	N-PORT
DCOR · Dimensional ETF Trust	0.00%	1,729 NS	2026년 4월 30일	N-PORT
IWV · iShares Trust	0.00%	16,926 SH	2026년 8월 8일	일간
DFAC · Dimensional ETF Trust	0.00%	19,277 NS	2026년 4월 30일	N-PORT
VXF · VANGUARD INDEX FUNDS	0.00%	895,869 SH	2026년 8월 8일	일간
VTI · VANGUARD INDEX FUNDS	0.00%	2,633,770 SH	2026년 8월 8일	일간
VTWV · VANGUARD SCOTTSDALE FUNDS	0.00%	9,454 SH	2026년 8월 8일	일간
VTHR · VANGUARD SCOTTSDALE FUNDS	0.00%	6,744 SH	2026년 8월 8일	일간

Codexis, Inc. - Common Stock 정보 위키백과 회사 개요

History

Pharmaceutical

Nutrition

Biotherapeutics

Life science

Technology

CDXS 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위

CDXS 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의

이동 평균 및 오버레이

거래량

오실레이터

모멘텀 및 추세

10년 성과 매출, 순이익, 마진 및 EPS 추세

가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?

수익성 총, 영업 및 순이익률; ROE, ROA, ROIC

재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성

성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR

주당 지표 EPS, 주당 순자산, 주당 현금 흐름, 주당 배당금

자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율

CDXS 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력

12개월 목표 주가

실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일

동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업

전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름

재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년

나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목

기관 투자자 (13F) 156개의 제출자 · $120.9M 전체 · 기준일 2026년 6월 30일

회사 내부자 40 명의 내부자 · 19 임원 · 20 이사

행동주의자 및 5% 이상 소유자 3 보유

ETF 보유 현황 26 ETF 보유